Medi-Vesp Pharma Private Limited
About Medi-Vesp Pharma Private Limited
Data last updated:
Medi-Vesp Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36100MH2013PTC250045. Its GSTIN is 27AAICM9190J1ZU (Maharashtra).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Vahidullah Najibullah Khan (Managing Director) and Sirajuddin Noorul Huda.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Building No 98 Shop No 4 New Mahad Colony Mankhurd, Mumbai, Maharashtra, India – 400043.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.48 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.83 Lakh (net margin 37.8%) and EBITDA of ₹2.83 Lakh (EBITDA margin 37.9%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medi-Vesp Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding No 98 Shop No 4 New Mahad Colony Mankhurd, Mumbai, Maharashtra, India – 400043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medi-Vesp Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medi-Vesp Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medi-Vesp Pharma Private Limited, buy the company report.
Financials of Medi-Vesp Pharma Private Limited
FY 2023 filings availableMedi-Vesp Pharma Private Limited reported revenue of ₹7.48 Lakh (down 29% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 29% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.9% | ||||
| Net Profit Margin | 37.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medi-Vesp Pharma Private Limited, buy the company report.
Board of directors of Medi-Vesp Pharma Private Limited
Medi-Vesp Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sirajuddin Noorul Huda Also directs: Britly Pharma LLP | Director | 13 Nov 2013 | 12 Years 11 Months | Current |
| Ehtesham Mohd Faiz Ahmed Shaikh | Director | 13 Nov 2013 | 12 Years 11 Months | Current |
| Vahidullah Najibullah Khan Also directs: Britly Pharma LLP | Managing Director | 13 Nov 2013 | 12 Years 11 Months | Current |
| Prakash Sawaldas Khetani Also directs: Britly Pharma LLP | Director | 13 Nov 2013 | 12 Years 11 Months | Current |
Auditor
Medi-Vesp Pharma Private Limited is audited by N J MAHTANI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N J MAHTANI & CO | FY 2020 | 124930W |
Shareholding
The shareholding of Medi-Vesp Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medi-Vesp Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medi-Vesp Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medi-Vesp Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medi-Vesp Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICM9190J1ZU | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medi-Vesp Pharma Private Limited, buy the company report.
Recent activity
Medi-Vesp Pharma Private Limited has 4 board changes on record since 2013: 4 appointments. The latest: Ehtesham Mohd Faiz Ahmed Shaikh was appointed as Director on 13 Nov 2013.
Frequently asked questions
Medi-Vesp Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 November 2013 (13+ years old) and is registered under CIN U36100MH2013PTC250045.
Medi-Vesp Pharma has 4 current directors:
- Vahidullah Najibullah Khan - Managing Director
- Sirajuddin Noorul Huda - Director
- Ehtesham Mohd Faiz Ahmed Shaikh - Director
- Prakash Sawaldas Khetani - Director
The latest financial statements of Medi-Vesp Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Medi-Vesp Pharma is 27AAICM9190J1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medi-Vesp Pharma is U36100MH2013PTC250045. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medi-Vesp Pharma was incorporated on 13 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Ehtesham Mohd Faiz Ahmed Shaikh was appointed as Director on 13 Nov 2013. Prakash Sawaldas Khetani was appointed as Director on 13 Nov 2013. Sirajuddin Noorul Huda was appointed as Director on 13 Nov 2013. Medi-Vesp Pharma has 4 board changes on record in total.
The registered office of Medi-Vesp Pharma is at Building No 98 Shop No 4 New Mahad Colony Mankhurd, Mumbai, Maharashtra, India – 400043.
Medi-Vesp Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Medi-Vesp Pharma is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.